Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Royal Society Africa Prize 2021 is awarded to Professor George Warimwe for his work on zoonoses vaccine development, capacity building in Africa, and his innovative research proposal. This Prize recognises research scientists based in Africa who are making an innovative contribution to the sciences.

George Warimwe

Professor George Warimwe works on various viral infections that are transmitted between humans and animals in Africa with a focus on vaccine development for their control. His vaccine programmes exploit synergies in human and livestock immunology to accelerate development of candidate vaccines for deployment in humans and the respective animal hosts of infection.

Using this approach, Professor Warimwe has developed ChAdOx1 RVF, a novel chimpanzee adenovirus vectored Rift Valley Fever vaccine, that is highly efficacious in multiple target livestock species (sheep, goats, cattle) and is currently in human phase I clinical trials. Read the publication Safety and efficacy of ChAdOx1 RVF vaccine against Rift Valley fever in pregnant sheep and goats on the Nature website

The full story is available on The Royal Society website

Similar stories

Congratulations new Associate Professors

Following the meeting of the Medical Sciences Divisional Committee to consider applications for the conferral of the title of Associate Professor, we are pleased to announce that Rashan Haniffa, Dorcas Kamuya, Isabella Oyier, Le Van Tan and Timothy Walker have been awarded the title Associate Professor

Reducing children’s exposure to malaria in their early years substantially cuts the risk of hospitalisation.

For the first time in more than two decades, a team from the KEMRI-Wellcome Trust Research Programme and University of Oxford have quantified the risk of children suffering severe outcomes from malaria - which can have a devastating impact on tens of thousands of children who are admitted to hospital with severe malaria every year.

Oxford retains top spot in world rankings for sixth consecutive year

The University of Oxford remains top of the table in latest Times Higher Education World University Rankings. In a year dominated by the ongoing Covid-19 pandemic, the rankings reflect the vital role of universities in understanding and managing the crisis as a number of institutions around the world saw significant boosts in their citation scores from Covid-19 focused research.

Tracking the introduction and spread of SARS-CoV-2 in coastal Kenya

A team of KWTRP scientists carried out a major genomic epidemiology of SARS-CoV-2 infections in Kenya during the early phase of the epidemic (March – July 2020). Researchers provide evidence for at least 35-40 unique introductions of the virus in the coast region – specifically the epidemic that was largely observed in Mombasa County.

RECOVERY Trial announced as overall winner of Best COVID-19 Response Project Award in the UK

The RECOVERY Trial has won the Project Management Institute’s Special Covid-19 UK Response Project Award. The award specifically recognised RECOVERY’s work to investigate whether the cheap steroid dexamethasone was an effective treatment for patients hospitalised with severe COVID-19.

Simple blood tests may help improve malaria diagnosis in clinical studies

About one-third of children diagnosed with severe malaria may instead have an alternative cause of illness, but simple blood tests could help researchers distinguish between the two and speed up research on new treatments.